West Pharmaceutical Services, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis

Date: June 15, 2018
Pages: 50
US$ 499.00
West Pharmaceutical Services, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)

Download PDF Leaflet

West Pharmaceutical Services, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
West Pharmaceutical Services, Inc. Due Diligence Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between West Pharmaceutical Services, Inc. and its competitors. This provides our Clients with a clear understanding of West Pharmaceutical Services, Inc. position in the Healthcare Equipment and Supplies Industry.

  • The report contains detailed information about West Pharmaceutical Services, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for West Pharmaceutical Services, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The West Pharmaceutical Services, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes West Pharmaceutical Services, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of West Pharmaceutical Services, Inc. business.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. manufactures components and systems for injectable drug delivery and plastic packaging and delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company’s products include stoppers and seals for vials and components used in syringe, intravenous and blood collection systems, prefillable syringe components, and safety and administration systems.


As of December 31, 2009, the company’s segments included Pharmaceutical Systems and Tech Group.

Pharmaceutical Systems Segment

This segment designs, manufactures, and sells various packaging components and systems used in parenteral drug delivery for the pharmaceutical, biopharmaceutical and generic industries. It has manufacturing facilities in North and South America, Europe and Asia Pacific, with affiliated companies in Mexico and Japan.

The company’s Pharmaceutical Systems segment consists of two operating segments, Americas and Europe/Asia Pacific. Its Pharmaceutical Systems business consists of various product lines, including pharmaceutical packaging, disposable medical components, safety and administration systems, and laboratory and other services.

Pharmaceutical Packaging: The company offers elastomeric stoppers and discs, which serve as primary closures for pharmaceutical vials; secondary closures for pharmaceutical vials called Flip-Off aluminum seals, consisting of an aluminum seal and a removable plastic button, and in some applications, just an aluminum seal; elastomeric plungers, needle shields and tip caps to fit most standard prefilled syringes and combination seals for dental cartridges and pen delivery systems; pharmaceutical containers, closures and dispensers, including the West Ready Pack system; enhanced component processing, such as NovaPure, Envision, VeriSure, Westar RS (ready-to-sterilize), and Westar RU (ready-to-use); Daikyo Crystal Zenith RU prefillable syringe system.

Disposable Medical Components: The company offers elastomeric components for blood collection systems, as well as flashback bulbs and sleeve stoppers for intravenous dispensing systems; elastomer and co-molded elastomer/plastic components for infusion and intravenous systems; non-filled syringe components; and dropper bulbs for applications such as eye, ear and nasal drops, diagnostic products and dispensing systems.

Safety and Administration Systems: The company offers sterile devices for the reconstitution, transfer and administration of drug products, including patented products such as the Mixject, Mix2Vial and vial adapters; and NovaGuard passive safety needle system.

Laboratory and Other Services: The company offers extractables and leachables testing, package/container testing, method development/validation, stability testing, process development and problem resolution.

Products and services include the Daikyo Crystal Zenith luer lock syringe, Envisionand the West Ready Pack system. The Daikyo Crystal Zenith syringe is the market’s silicone-free, ready-to-use prefillable syringe that offers pharmaceutical and biopharmaceutical companies a total system solution that can mitigate the risks associated with glass syringes. West’s Envision components (plungers and stoppers) are inspected by an automated vision inspection system. The West Ready Pack system is a one-source solution used for pharmaceutical research and development and clinical work.

The company’s tamper-evident Flip-Off seals consist of a metal overseal and a molded plastic cap that is removed to permit needle access to the drug-vial contents. These are sold in a range of sizes and colors to meet customers’ needs for product identification and differentiation. The seals can be provided using proprietary printing and embossing technology for multiple layers of protection, such as, point-of-use instructions, item-level information such as vial contents, drug dosage and strength, and cautionary statements that can serve as counterfeiting deterrence.

Elastomeric components are offered in various standard and customer-specific configurations and formulations and are available with advanced barrier film

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. West Pharmaceutical Services, Inc. Direct Competitors
5.2. Comparison of West Pharmaceutical Services, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of West Pharmaceutical Services, Inc. and Direct Competitors Stock Charts
5.4. West Pharmaceutical Services, Inc. Industry Analysis
  5.4.1. Healthcare Equipment/Supplies Industry Snapshot
  5.4.2. West Pharmaceutical Services, Inc. Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





West Pharmaceutical Services, Inc. Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
West Pharmaceutical Services, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
West Pharmaceutical Services, Inc. Major Shareholders
West Pharmaceutical Services, Inc. History
West Pharmaceutical Services, Inc. Products
Revenues by Segment
Revenues by Region
West Pharmaceutical Services, Inc. Offices and Representations
West Pharmaceutical Services, Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
West Pharmaceutical Services, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
West Pharmaceutical Services, Inc. Capital Market Snapshot
West Pharmaceutical Services, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
West Pharmaceutical Services, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
West Pharmaceutical Services, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1


West Pharmaceutical Services, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
West Pharmaceutical Services, Inc. 1-year Stock Charts
West Pharmaceutical Services, Inc. 5-year Stock Charts
West Pharmaceutical Services, Inc. vs. Main Indexes 1-year Stock Chart
West Pharmaceutical Services, Inc. vs. Direct Competitors 1-year Stock Charts
West Pharmaceutical Services, Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top

Ask Your Question

West Pharmaceutical Services, Inc. Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: